ARTICLE | Company News
Biogen looks to ex-U.S. markets for growth
April 24, 2018 9:16 PM UTC
Biogen Inc. (NASDAQ:BIIB) perceives greater long-term growth opportunities than anticipated in the EU and emerging markets, the company's CEO Michel Vounatsos said on its earnings call Tuesday, while noting that the U.S. market remains its key driver of growth.
The bellwether reported an overall increase in ex-U.S. sales in the first quarter, even as it saw a decline in U.S. sales for some drugs, including spinal muscular atrophy drug Spinraza nusinersen...